Chronic lymphocytic leukemia.

Chronic lymphocytic leukemia (CLL), the most frequent form of leukemia in Western countries, is characterized by the clonal proliferation and accumulation of neoplastic B lymphocytes in the blood, bone marrow, lymph nodes, and spleen. The median age of patients at diagnosis is 65 years, with only 10 to 15 percent under 50 years of age. In most series, more men than women are affected. The course of the disease is variable. Whereas some patients with CLL have a normal life span, others die within five years after diagnosis. During the past few years, important advances have been made in the . . .

[1]  A. Delannoy,et al.  2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL). , 1995, Leukemia.

[2]  A Benner,et al.  p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. , 1995, Blood.

[3]  E. Raveche,et al.  Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide. , 1995, Leukemia research.

[4]  A. Saven,et al.  2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Angelopoulou,et al.  Effective treatment of disease‐related anaemia in B‐chronic lymphocytic leukaemia patients with recombinant human erythropoietin , 1995, British journal of haematology.

[6]  E. Montserrat,et al.  Chronic lymphocytic leukemia: present status. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  S. Singhal,et al.  Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia. , 1994, Bone marrow transplantation.

[8]  D. Catovsky,et al.  The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. , 1994, Leukemia.

[9]  E. Montserrat,et al.  Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia. , 1994, Leukemia.

[10]  F. Ries,et al.  Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes , 1994, British journal of haematology.

[11]  C. Geisler,et al.  Treatment of hypogammaglobulinemia in chronic lymphocytic leukaemia by low‐dose intravenous gammaglobulin , 1994, European journal of haematology.

[12]  H. Tilly,et al.  Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic value. , 1994, Leukemia.

[13]  G. Dighiero,et al.  The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. , 1994, Immunology today.

[14]  G. Gaidano,et al.  Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. , 1994, The American journal of pathology.

[15]  S. Molica Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment. , 1994, Leukemia & lymphoma.

[16]  B. Andersson,et al.  Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Pirker,et al.  MDR1 gene expression in chronic lymphocytic leukemia. , 1994, Leukemia & lymphoma.

[18]  G. Inghirami,et al.  Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma) , 1994 .

[19]  G. Gahrton,et al.  5 Cytogenetics in CLL and related disorders , 1993 .

[20]  E. Montserrat,et al.  6 Chronic lymphocytic leukaemia: Prognostic factors and natural history , 1993 .

[21]  E. Newcomb,et al.  p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression , 1993 .

[22]  H. Kantarjian,et al.  Richter's syndrome: a report on 39 patients. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  K. Ganeshaguru,et al.  Autocrine and paracrine growth loops in chronic lymphocytic leukemia. , 1993, Seminars in hematology.

[24]  John Calvin Reed,et al.  bcl-2 Gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia , 1993 .

[25]  D. Neuberg,et al.  Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. , 1993, Blood.

[26]  A. Berrebi,et al.  Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia , 1993, American journal of hematology.

[27]  D. Catovsky,et al.  Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. , 1993, Blood.

[28]  L. Hawthorn,et al.  The consistent 13q14 translocation breakpoint seen in chronic B-cell leukaemia (BCLL) involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene. , 1993, Oncogene.

[29]  E. Estey,et al.  Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. , 1993, Blood.

[30]  A. Novarino,et al.  The nature of the B lymphocyte in B-chronic lymphocytic leukemia. , 1993, Blood cells.

[31]  E. Anaissie,et al.  Listeriosis in Patients with Chronic Lymphocytic Leukemia Who Were Treated with Fludarabine and Prednisone , 1992, Annals of Internal Medicine.

[32]  M. Tsan,et al.  Cyclosporine and prednisone therapy for pure red cell aplasia in patients with chronic lymphocytic leukemia , 1992, American journal of hematology/oncology.

[33]  H. Kantarjian,et al.  Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis. , 1992, Blood.

[34]  M. Linet,et al.  Chronic leukaemias. , 1992, Bailliere's clinical haematology.

[35]  E. Montserrat,et al.  alpha Interferon in chronic lymphocytic leukaemia. , 1991, European journal of cancer.

[36]  H Tesch,et al.  Human chronic lymphocytic leukemia cells regularly express mRNAs of the protooncogenes lck and c-fgr. , 1991, Leukemia research.

[37]  D. Catovsky,et al.  CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3. , 1991, Leukemia & lymphoma.

[38]  S. Rodenhuis,et al.  Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of Cancer. , 1990, Journal of the National Cancer Institute.

[39]  M. Raffeld,et al.  Chromosomal translocation t(14;19) as indicated by bcl-3 rearrangement is a rare phenomenon in non-Hodgkin's lymphoma and chronic lymphocytic leukemia: a molecular genetic analysis of 176 cases. , 1990, Leukemia.

[40]  B. Grosbois,et al.  Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): results of a randomized clinical trial on 612 patients. The French Cooperative Group on Chronic Lymphocytic Leukemia. , 1990, Blood.

[41]  H. Gralnick,et al.  Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. , 1989, Journal of clinical pathology.

[42]  M. Grever,et al.  Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group , 1988, American journal of hematology.

[43]  A. Randomized Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. , 1988 .

[44]  Ciril Rozman,et al.  Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance , 1986, British journal of haematology.

[45]  E. Montserrat,et al.  Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. , 1984, Blood.

[46]  E. Montserrat,et al.  Prognosis of chronic lymphocytic leukemia: a multivariate survival analysis of 150 cases , 1982 .

[47]  Mark J. Thomas,et al.  A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis , 1981, Cancer.

[48]  D. Catovsky,et al.  ‘Prolymphocytoid’ Transformation of Chronic Lymphocytic Leukaemia , 1979, British journal of haematology.

[49]  E. Cronkite,et al.  Clinical staging of chronic lymphocytic leukemia. , 1975, Blood.